Despite being a growth investor, I don't always invest in healthcare companies. When it comes to the pharma sector, especially, I am very cautious given regulatory uncertainties and the difficulty in predicting the outcomes of clinical trials. However, there are other types of healthcare companies thatDilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged violations of the Securities Exchange Act, specifically for making false and misleading statements regarding its financial reporting [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, with a deadline for lead plaintiff appointments set for March 9, 2026 [2]. - The complaint alleges that Ardent Health utilized a 180-day cliff on accounts receivable, allowing the company to report inflated amounts and delay loss recognition, rendering its public statements materially misleading [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although such an appointment is not necessary to participate in any recovery [2][3].

NEW ORLEANS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Agilon Health, Inc. regarding a class action lawsuit due to alleged misleading statements and guidance issued by the company during a specified period [1][3]. Group 1: Allegations - The complaint alleges that Agilon Health's defendants issued materially false and/or misleading statements and failed to disclose critical information during the class period from February 26, 2025, to August 4, 2025 [3]. - Specific allegations include that the defendants recklessly provided guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - Additionally, it is claimed that the defendants overstated the immediate positive financial impact from strategic actions taken to mitigate risk, leading to materially false and misleading statements about the company's business and prospects [3]. Group 2: Class Action Details - Shareholders who purchased shares of Agilon Health during the class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for March 2, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. - Participation in the case incurs no cost or obligation for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [5].

PresentationPresenting for the company will be Jim Boyle, their CEO. Mike Drazin, their CFO, is going to join us for the Q&A portion. But before we get started, Karen King, who is Head of Investor Relations, is just going to read an opening reg FDC.All right. Great. Good afternoon, everyone, and welcome. My name is Lisa Gill, and I head up health care services here at JPMorgan. It is with great pleasure this afternoon that I introduce Medline for their first JPMorgan Healthcare Conference as a publicly trad ...

PresentationGreat. Thank you all for being here. My name is John Stansel. I'm a member of the health care services equity research team here at JPMorgan. And we're thrilled to be joined by Alignment Healthcare, where we have CEO, John Kao; and CFO, Jim Head. John is going to give a presentation, and then we're going to move to some Q&A after that.John KaoFounder, CEO & Director Thanks, John. Good morning, everybody. Can you guys hear me okay? All right. Let's see here. Let me see if I can figure this out. O ...

PresentationGood morning, everyone. My name is Lisa Gill, and I head up Health Care Services here at JPMorgan. This morning, with great pleasure, I have with us Omada Health. This is actually Omada Health's first time as a public company presenting. I know you've been here many times as a private company. Presenting for the company will be Sean Duffy, and then we will have a little fireside chat afterwards with Wei-Li and Steve Hooks. So with that, let me turn it over to you, Sean.Sean DuffyCo-Founder, CEO ...

PresentationThank you all for joining us here in person. For those who are joining us via webcast, my name is Ben Rossi, and I'm the health care facilities analyst here at JPMorgan. We are excited to welcome Aveanna back to the stage this morning. With us here today are CEO, Jeff Shaner, and CFO, Matt Buckhalter. Thank you both for being here.Jeffrey ShanerCEO & Director Thanks, Ben, and good morning. As Ben said, I'm Jeff Shaner, the CEO of Aveanna Healthcare, and I'm here today with Matt Buckhalter, our C ...

PresentationJoining us today will be CEO, Dr. Howard Berger, CFO, Mark Stolper, Chief Strategy Officer; Dr. Greg Sorensen and CEO of RadNet Digital, Kees Wesdorp. They'll be running us through a brief set of materials, and we'll ask you to hold off on any Q&A until the end.Good morning, everyone, and welcome again to the 44th Annual JPMorgan Healthcare Conference. My name is Matt Mckean, and I'm an associate here at JPM. And it's my pleasure to introduce our next presenting company, RadNet.Howard BergerChai ...